Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear envelope integral membrane protein 2 (NEMP2) is a protein encoded by the NEMP2 gene and localizes to the inner membrane of the nuclear envelope[1][2][3][9]. It is a predicted transmembrane protein believed to be involved in maintaining nuclear envelope structure and organization[2][3]. NEMP2 has been associated with certain genetic diseases, such as Hemochromatosis type 4 and cone-rod dystrophy 1, but there is limited evidence of its direct role as a therapeutic target or established biomarker[2]. No drugs are currently known to interact with this protein in a clinical context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear envelope integral membrane protein 2 (NEMP2).